Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Front Immunol
; 12: 663865, 2021.
Article
in En
| MEDLINE
| ID: mdl-34046035
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telomerase
/
Cancer Vaccines
/
Ipilimumab
/
Melanoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: